Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Aromasin May Be Effective Treatment for Mesothelioma: Study April 11, 2014 Irvin Jackson Add Your Comments The findings of a new study indicate that the breast cancer drug Aromasin may be an effective treatment for mesothelioma, a rare and deadly form of cancer associated with exposure to asbestos. Researchers from Italy’s Regina Elena National Cancer Institute published findings in the March issue of the medical journal Molecular Cancer, which suggest that Aromasin retards the growth and spread of mesothelioma. The study suggests that Aromasin may be used to slow mesothelioma, which is almost always fatal due to the advanced stage the cancer is in by the time it is discovered. Learn More About Mesothelioma Lawsuits Exposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Mesothelioma Lawsuits Exposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Mesothelioma is only known to occur among individuals exposed to asbestos, which was commonly used for decades in a variety of manufacturing and construction applications. There is no known cure for the disease, and it is usually not diagnosed until decades after asbestos exposure. As a result individuals typically have a very short life expectancy after discovery, given the advanced stage the cancer is often in. Researchers in this latest say it could be possible to reduce proliferation of mesothelioma cells with Aromasin treatments. The findings of this study show significant reduction the cell proliferation, survival, migration and block of mesothelioma cells. Mice infected with human mesothelioma cells saw significant tumor reduction when given Aromasin. They also found that the drug appears to inhibit CD44, a surface glycoprotein involved in cell migration. When Aromasin was combined with Alimta, a commonly-used mesothelioma drug, researchers said tumors were reduced so small that they had trouble collecting sample cells. Researchers are calling for further studies and human clinical trials. Asbestos Litigation Over Mesothelioma Although asbestos has been banned for more than 30 years, new cases of the deadly disease continue to surface given the long latency period of 20 to 40 years between exposure and diagnosis of mesothelioma. Asbestos was use peaking in 1973, and previous reports by the U.S. Centers for Disease Control and Prevention (CDC) suggest that the number of cases of malignant mesothelioma are just now peaking. Over the past few decades, mesothelioma lawsuits have become the longest-running mass tort litigation in U.S. history, with more than 600,000 people having filed a lawsuit against more than 6,000 defendants after being diagnosed with mesothelioma or another asbestos-related injuy caused by inhaling the fibers. In addition to cases for individuals directly exposed, in recent years there have been a growing number of second-hand asbestos exposure lawsuits brought on behalf of family members were exposed to fibers carried home on clothing or in the hair of individuals working with the material. Cases have been brought by individuals who were exposed as young children or babies when their parents would hold them after returning home from work with asbestos. Tags: Aromasin, Asbestos, Asbestos Exposure, Breast Cancer, Mesothelioma Image Credit: | More Mesothelioma Lawsuit Stories EPA Asbestos Risk Assessment Finds Firefighters, Construction Workers Face Highest Risks April 18, 2024 EPA Bans Last Uses of Toxic Asbestos in the United States March 19, 2024 U.S. Government Is Falling Behind Inspecting Federal Buildings for Toxic Asbestos, GAO Report Warns March 11, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: today) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: yesterday) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025) Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (Posted: 2 days ago) Hair relaxer lawsuit plaintiffs and defendants have selected 32 claims to be prepared for early test trials, focusing on ovarian, uterine and endometrial cancer injuries. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)
EPA Asbestos Risk Assessment Finds Firefighters, Construction Workers Face Highest Risks April 18, 2024
U.S. Government Is Falling Behind Inspecting Federal Buildings for Toxic Asbestos, GAO Report Warns March 11, 2024
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: today) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: yesterday) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (Posted: 2 days ago) Hair relaxer lawsuit plaintiffs and defendants have selected 32 claims to be prepared for early test trials, focusing on ovarian, uterine and endometrial cancer injuries. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)